CLSN [NASD]
Celsion Corporation
Index- P/E- EPS (ttm)-3.91 Insider Own0.40% Shs Outstand5.77M Perf Week-7.81%
Market Cap16.59M Forward P/E- EPS next Y-4.25 Insider Trans64.25% Shs Float5.73M Perf Month-24.12%
Income-20.80M PEG- EPS next Q-0.86 Inst Own10.00% Short Float3.11% Perf Quarter-56.32%
Sales0.50M P/S33.18 EPS this Y62.00% Inst Trans0.86% Short Ratio0.53 Perf Half Y-79.02%
Book/sh8.02 P/B0.29 EPS next Y-3.60% ROA-34.00% Target Price32.67 Perf Year-85.95%
Cash/sh5.87 P/C0.40 EPS next 5Y- ROE-45.30% 52W Range2.30 - 23.25 Perf YTD-70.86%
Dividend- P/FCF- EPS past 5Y53.60% ROI-35.40% 52W High-89.85% Beta2.29
Dividend %- Quick Ratio6.60 Sales past 5Y0.00% Gross Margin- 52W Low2.61% ATR0.25
Employees29 Current Ratio6.60 Sales Q/Q0.00% Oper. Margin- RSI (14)30.33 Volatility8.18% 8.42%
OptionableYes Debt/Eq0.00 EPS Q/Q-41.00% Profit Margin- Rel Volume0.08 Prev Close2.36
ShortableYes LT Debt/Eq0.13 EarningsMay 16 BMO Payout- Avg Volume333.75K Price2.36
Recom2.30 SMA20-16.27% SMA50-39.53% SMA200-74.55% Volume27,723 Change0.00%
Jul-16-20Downgrade Oppenheimer Outperform → Perform
Jul-14-20Downgrade Dawson James Buy → Neutral
Oct-04-17Upgrade Maxim Group Hold → Buy $7
Apr-10-17Resumed Rodman & Renshaw Buy $1.50
Nov-10-16Downgrade Maxim Group Buy → Hold
Jul-12-16Resumed H.C. Wainwright Buy $3
Jan-19-16Reiterated Maxim Group Buy $12 → $9
Jul-15-15Initiated Maxim Group Buy $12
Jan-10-14Resumed HC Wainwright Buy $5 → $8
Aug-16-12Reiterated Griffin Securities Buy $10 → $18
Feb-16-12Initiated Brean Murray Buy $7
Oct-26-11Initiated Rodman & Renshaw Mkt Outperform $6
Nov-11-09Initiated Needham Buy $7
May-16-22 08:00AM  
May-10-22 08:30AM  
May-09-22 08:30AM  
Apr-21-22 03:24PM  
11:30AM  
Apr-14-22 08:30AM  
Apr-12-22 08:30AM  
Apr-08-22 04:30PM  
Apr-06-22 08:30AM  
08:30AM  
Apr-05-22 06:15AM  
Apr-01-22 08:00AM  
Mar-31-22 08:30AM  
Mar-24-22 09:00AM  
Feb-28-22 09:00AM  
08:30AM  
Feb-17-22 08:30AM  
Jan-31-22 08:00AM  
Jan-13-22 05:30PM  
Jan-10-22 08:45PM  
Nov-29-21 08:30AM  
Nov-17-21 07:25AM  
Nov-15-21 08:30AM  
Nov-09-21 09:00AM  
Nov-08-21 09:00AM  
08:30AM  
Oct-15-21 09:00AM  
Oct-12-21 09:00AM  
Oct-11-21 09:00AM  
08:09AM  
06:44AM  
Oct-05-21 09:00AM  
Sep-30-21 09:00AM  
Sep-17-21 09:00AM  
Sep-03-21 12:40PM  
Sep-02-21 10:02AM  
08:00AM  
Aug-14-21 05:02AM  
Aug-12-21 08:00AM  
Aug-05-21 08:00AM  
Jul-29-21 10:00AM  
Jul-19-21 08:00AM  
Jul-15-21 08:00AM  
Jul-14-21 09:11AM  
Jul-01-21 08:00AM  
Jun-23-21 08:00AM  
Jun-21-21 08:00AM  
Jun-11-21 08:30AM  
Jun-09-21 08:00AM  
Jun-08-21 08:00AM  
Jun-07-21 05:00PM  
Jun-04-21 10:11AM  
Jun-02-21 08:00AM  
May-27-21 08:30AM  
May-14-21 08:15AM  
08:00AM  
May-11-21 08:00AM  
May-07-21 08:30AM  
Apr-22-21 08:30AM  
Apr-05-21 05:00PM  
Apr-01-21 09:23AM  
08:30AM  
Mar-31-21 08:00AM  
Mar-19-21 09:15AM  
08:45AM  
Mar-12-21 08:45AM  
Mar-05-21 12:00PM  
08:32AM  
Mar-02-21 08:45AM  
Mar-01-21 12:46PM  
Feb-26-21 08:45AM  
Feb-25-21 07:26PM  
05:00PM  
04:10PM  
02:45PM  
11:34AM  
08:45AM  
Feb-23-21 08:00AM  
Feb-22-21 07:30AM  
05:17AM  
Feb-12-21 08:30AM  
03:43AM  
Feb-11-21 08:30AM  
Feb-09-21 08:00AM  
Feb-06-21 05:16PM  
Jan-29-21 08:32AM  
Jan-28-21 08:00AM  
Jan-26-21 05:00PM  
Jan-22-21 08:40AM  
Jan-21-21 11:53PM  
10:01AM  
08:47AM  
Dec-29-20 01:20PM  
10:30AM  
09:37AM  
09:10AM  
Dec-28-20 12:55PM  
09:24AM  
Dec-26-20 09:00AM  
Dec-24-20 05:02PM  
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tardugno Michael HChairman, President and CEOApr 12Buy3.534,00014,12916,513Apr 12 02:19 PM
Fritz Frederick J.DirectorApr 08Buy4.055,00020,25011,766Apr 11 03:09 PM
Fritz Frederick J.DirectorMar 02Buy4.692,0009,3726,766Mar 03 12:49 PM
Fritz Frederick J.DirectorOct 07Buy0.8820,00017,60071,491Oct 08 08:50 AM